BioSpace News Archive

Ginkgo Bioworks, the leading horizontal platform for cell programming and biosecurity, and the Government of the Republic of Panama’s Gorgas Memorial Institute for Health Studies, announced that they have entered into a Memorandum of Understanding with the intent to develop and implement new biosecurity capabilities in Latin America.

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that it has entered a collaboration and license agreement with Novartis for the discovery, development and commercialization of a novel medicine for patients with lipoprotein(a), or Lp(a)-driven cardiovascular disease (CVD).

Bicycle Therapeutics Limited plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today reported financial results for the second quarter ended June 30, 2023 and provided recent corporate updates.

Coya Therapeutics, Inc. today announced that Dr. Fred Grossman, President and Chief Medical Officer, is presenting at BTIG’s Virtual Biotechnology Conference 2023, Tuesday, August 8th at 1:30 p.m. ET.

Exscientia plc (Nasdaq: EXAI) will report financial results for the second quarter ended June 30, 2023, on Thursday August 10, 2023, before the open of U.S. markets.

CareDx, Inc. today announced it will report financial results for the second quarter 2023 after market close on Tuesday, August 8th , 2023.

Celsius Therapeutics today announced the initiation of dosing in the company’s first-in-human Phase 1 clinical trial of CEL383 in healthy volunteers.

AlloVir, Inc. (Nasdaq: ALVR), a late-clinical stage allogeneic T cell immunotherapy company, today reported financial results from the second quarter ended June 30, 2023.

Bausch Health Companies Inc. (NYSE/TSX:BHC) (“Bausch Health” or the “Company” or “we” or “our”) today announced its second-quarter 2023 financial results and various other key updates from the quarter.

OpGen, Inc. announced that the Company will provide a business update and report its second quarter 2023 financial results after the close of the U.S. financial markets on Thursday, August 10th 2023.